Company Analysis

Krystal Biotech, Inc. (KRYS)

Nasdaq: KRYS · Biological Products, (No Diagnostic Substances) · Pittsburgh, PA · filing with the SEC since 2017
Grade7.6
◀ Past 7.1● Present 9.0▶ Future 6.1

The company now

Krystal Biotech, Inc. is classed by the SEC under Biological Products, (No Diagnostic Substances) (industry code 2836), based in Pittsburgh, PA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $389 million and a profit of $205 million (its filed statements).

From its filings and filed figures; the desk's account of it is not written yet.

The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.

SI Assistanton KRYS · research, not advice